Selected research
Market Outlook & Growth Opportunities
Global Genome Chip Market Outlook and Growth Opportunities 2026
Market perspective
The global Genome Chip market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Genome Chip is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Genome Chip is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Genome Chip is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Genome Chip market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Genome Chip market include Illumnia, Thermo Fisher, Agilent, Scienion AG, SCHOTT, Arrayit, Standard BioTools, QIAGEN and GeneCopoeia, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Genome Chip market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Genome Chip and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Genome Chip sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Genome Chip market size, projected growth trends, production technologies, key applications, and end-use industries.
Genome Chip Segment by Company
Illumnia
Thermo Fisher
Agilent
Scienion AG
SCHOTT
Arrayit
Standard BioTools
QIAGEN
GeneCopoeia
Oxford Gene Technology
Axela Biosciences
Genome Chip Segment by Type
Oligonucleotide DNA Chip
Complementary DNA Chip
Genome Chip Segment by Application
Research Centers
Clinical
Commercial Molecular Diagnostic
Others
Genome Chip Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Genome Chip status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Genome Chip market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Genome Chip significant trends, drivers, influence factors in global and regions.
6. To analyze Genome Chip competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genome Chip market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Genome Chip and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genome Chip.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Genome Chip market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Genome Chip industry.
Chapter 3: Detailed analysis of Genome Chip manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Genome Chip in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Genome Chip in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Genome Chip Industry Trends
Table 2. Genome Chip Industry Drivers
Table 3. Genome Chip Industry Opportunities and Challenges
Table 4. Genome Chip Industry Restraints
Table 5. Global Genome Chip Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Genome Chip Revenue Share by Company (2021-2026)
Table 7. Global Genome Chip Sales Volume by Company (k pcs) & (2021-2026)
Table 8. Global Genome Chip Sales Volume Share by Company (2021-2026)
Table 9. Global Genome Chip Average Price (USD/pcs) of Company (2021-2026)
Table 10. Global Genome Chip Company Ranking, (2024-2026) & (USD Million)
Table 11. Global Genome Chip Key Company Manufacturing Base & Headquarters
Table 12. Global Genome Chip Company, Product Type & Application
Table 13. Global Genome Chip Company Establishment Date
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global Genome Chip by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Significant Companies of Oligonucleotide DNA Chip
Table 18. Significant Companies of Complementary DNA Chip
Table 19. Global Genome Chip Sales Volume by Type 2021 VS 2025 VS 2032 (k pcs)
Table 20. Global Genome Chip Sales Volume by Type (2021-2026) & (k pcs)
Table 21. Global Genome Chip Sales Volume by Type (2027-2032) & (k pcs)
Table 22. Global Genome Chip Sales Volume Share by Type (2021-2026)
Table 23. Global Genome Chip Sales Volume Share by Type (2027-2032)
Table 24. Global Genome Chip Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 25. Global Genome Chip Sales Value by Type (2021-2026) & (US$ Million)
Table 26. Global Genome Chip Sales Value by Type (2027-2032) & (US$ Million)
Table 27. Global Genome Chip Sales Value Share by Type (2021-2026)
Table 28. Global Genome Chip Sales Value Share by Type (2027-2032)
Table 29. Significant Companies of Research Centers
Table 30. Significant Companies of Clinical
Table 31. Significant Companies of Commercial Molecular Diagnostic
Table 32. Significant Companies of Others
Table 33. Global Genome Chip Sales Volume by Application 2021 VS 2025 VS 2032 (k pcs)
Table 34. Global Genome Chip Sales Volume by Application (2021-2026) & (k pcs)
Table 35. Global Genome Chip Sales Volume by Application (2027-2032) & (k pcs)
Table 36. Global Genome Chip Sales Volume Share by Application (2021-2026)
Table 37. Global Genome Chip Sales Volume Share by Application (2027-2032)
Table 38. Global Genome Chip Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 39. Global Genome Chip Sales Value by Application (2021-2026) & (US$ Million)
Table 40. Global Genome Chip Sales Value by Application (2027-2032) & (US$ Million)
Table 41. Global Genome Chip Sales Value Share by Application (2021-2026)
Table 42. Global Genome Chip Sales Value Share by Application (2027-2032)
Table 43. Global Genome Chip Sales by Region: 2021 VS 2025 VS 2032 (k pcs)
Table 44. Global Genome Chip Sales by Region (2021-2026) & (k pcs)
Table 45. Global Genome Chip Sales Market Share by Region (2021-2026)
Table 46. Global Genome Chip Sales by Region (2027-2032) & (k pcs)
Table 47. Global Genome Chip Sales Market Share by Region (2027-2032)
Table 48. Global Genome Chip Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 49. Global Genome Chip Sales Value by Region (2021-2026) & (US$ Million)
Table 50. Global Genome Chip Sales Value Share by Region (2021-2026)
Table 51. Global Genome Chip Sales Value by Region (2027-2032) & (US$ Million)
Table 52. Global Genome Chip Sales Value Share by Region (2027-2032)
Table 53. Global Genome Chip Market Average Price (USD/pcs) by Region (2021-2026)
Table 54. Global Genome Chip Market Average Price (USD/pcs) by Region (2027-2032)
Table 55. Global Genome Chip Sales by Country: 2021 VS 2025 VS 2032 (k pcs)
Table 56. Global Genome Chip Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 57. Global Genome Chip Sales by Country (2021-2026) & (k pcs)
Table 58. Global Genome Chip Sales Market Share by Country (2021-2026)
Table 59. Global Genome Chip Sales by Country (2027-2032) & (k pcs)
Table 60. Global Genome Chip Sales Market Share by Country (2027-2032)
Table 61. Global Genome Chip Sales Value by Country (2021-2026) & (US$ Million)
Table 62. Global Genome Chip Sales Value Market Share by Country (2021-2026)
Table 63. Global Genome Chip Sales Value by Country (2027-2032) & (US$ Million)
Table 64. Global Genome Chip Sales Value Market Share by Country (2027-2032)
Table 65. Illumnia Company Information
Table 66. Illumnia Business Overview
Table 67. Illumnia Genome Chip Sales (k pcs), Value (US$ Million), Price (USD/pcs) and Gross Margin (2021-2026)
Table 68. Illumnia Genome Chip Product Portfolio
Table 69. Illumnia Recent Development
Table 70. Thermo Fisher Company Information
Table 71. Thermo Fisher Business Overview
Table 72. Thermo Fisher Genome Chip Sales (k pcs), Value (US$ Million), Price (USD/pcs) and Gross Margin (2021-2026)
Table 73. Thermo Fisher Genome Chip Product Portfolio
Table 74. Thermo Fisher Recent Development
Table 75. Agilent Company Information
Table 76. Agilent Business Overview
Table 77. Agilent Genome Chip Sales (k pcs), Value (US$ Million), Price (USD/pcs) and Gross Margin (2021-2026)
Table 78. Agilent Genome Chip Product Portfolio
Table 79. Agilent Recent Development
Table 80. Scienion AG Company Information
Table 81. Scienion AG Business Overview
Table 82. Scienion AG Genome Chip Sales (k pcs), Value (US$ Million), Price (USD/pcs) and Gross Margin (2021-2026)
Table 83. Scienion AG Genome Chip Product Portfolio
Table 84. Scienion AG Recent Development
Table 85. SCHOTT Company Information
Table 86. SCHOTT Business Overview
Table 87. SCHOTT Genome Chip Sales (k pcs), Value (US$ Million), Price (USD/pcs) and Gross Margin (2021-2026)
Table 88. SCHOTT Genome Chip Product Portfolio
Table 89. SCHOTT Recent Development
Table 90. Arrayit Company Information
Table 91. Arrayit Business Overview
Table 92. Arrayit Genome Chip Sales (k pcs), Value (US$ Million), Price (USD/pcs) and Gross Margin (2021-2026)
Table 93. Arrayit Genome Chip Product Portfolio
Table 94. Arrayit Recent Development
Table 95. Standard BioTools Company Information
Table 96. Standard BioTools Business Overview
Table 97. Standard BioTools Genome Chip Sales (k pcs), Value (US$ Million), Price (USD/pcs) and Gross Margin (2021-2026)
Table 98. Standard BioTools Genome Chip Product Portfolio
Table 99. Standard BioTools Recent Development
Table 100. QIAGEN Company Information
Table 101. QIAGEN Business Overview
Table 102. QIAGEN Genome Chip Sales (k pcs), Value (US$ Million), Price (USD/pcs) and Gross Margin (2021-2026)
Table 103. QIAGEN Genome Chip Product Portfolio
Table 104. QIAGEN Recent Development
Table 105. GeneCopoeia Company Information
Table 106. GeneCopoeia Business Overview
Table 107. GeneCopoeia Genome Chip Sales (k pcs), Value (US$ Million), Price (USD/pcs) and Gross Margin (2021-2026)
Table 108. GeneCopoeia Genome Chip Product Portfolio
Table 109. GeneCopoeia Recent Development
Table 110. Oxford Gene Technology Company Information
Table 111. Oxford Gene Technology Business Overview
Table 112. Oxford Gene Technology Genome Chip Sales (k pcs), Value (US$ Million), Price (USD/pcs) and Gross Margin (2021-2026)
Table 113. Oxford Gene Technology Genome Chip Product Portfolio
Table 114. Oxford Gene Technology Recent Development
Table 115. Axela Biosciences Company Information
Table 116. Axela Biosciences Business Overview
Table 117. Axela Biosciences Genome Chip Sales (k pcs), Value (US$ Million), Price (USD/pcs) and Gross Margin (2021-2026)
Table 118. Axela Biosciences Genome Chip Product Portfolio
Table 119. Axela Biosciences Recent Development
Table 120. Key Raw Materials
Table 121. Raw Materials Key Suppliers
Table 122. Genome Chip Distributors List
Table 123. Genome Chip Customers List
Table 124. Research Programs/Design for This Report
Table 125. Authors List of This Report
Table 126. Secondary Sources
Table 127. Primary Sources
List of Figures
Figure 1. Genome Chip Product Image
Figure 2. Global Genome Chip Sales Value (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Genome Chip Sales Value (2021-2032) & (US$ Million)
Figure 4. Global Genome Chip Sales (2021-2032) & (k pcs)
Figure 5. Global Genome Chip Sales Average Price (USD/pcs) & (2021-2032)
Figure 6. Global Genome Chip Company Revenue Ranking in 2025 (US$ Million)
Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 9. Oligonucleotide DNA Chip Image
Figure 10. Complementary DNA Chip Image
Figure 11. Global Genome Chip Sales Volume by Type (2021 VS 2025 VS 2032) & (k pcs)
Figure 12. Global Genome Chip Sales Volume Share 2021 VS 2025 VS 2032
Figure 13. Global Genome Chip Sales Volume Share by Type (2021-2032)
Figure 14. Global Genome Chip Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 15. Global Genome Chip Sales Value Share 2021 VS 2025 VS 2032
Figure 16. Global Genome Chip Sales Value Share by Type (2021-2032)
Figure 17. Research Centers Image
Figure 18. Clinical Image
Figure 19. Commercial Molecular Diagnostic Image
Figure 20. Others Image
Figure 21. Global Genome Chip Sales Volume by Application (2021 VS 2025 VS 2032) & (k pcs)
Figure 22. Global Genome Chip Sales Volume Share 2021 VS 2025 VS 2032
Figure 23. Global Genome Chip Sales Volume Share by Application (2021-2032)
Figure 24. Global Genome Chip Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 25. Global Genome Chip Sales Value Share 2021 VS 2025 VS 2032
Figure 26. Global Genome Chip Sales Value Share by Application (2021-2032)
Figure 27. Global Genome Chip Sales by Region: 2021 VS 2025 VS 2032 (k pcs)
Figure 28. Global Genome Chip Sales Market Share by Region: 2021 VS 2025 VS 2032
Figure 29. Global Genome Chip Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 30. Global Genome Chip Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 31. North America Genome Chip Sales Value (2021-2032) & (US$ Million)
Figure 32. North America Genome Chip Sales Value Share by Country (%), 2025 VS 2032
Figure 33. Europe Genome Chip Sales Value (2021-2032) & (US$ Million)
Figure 34. Europe Genome Chip Sales Value Share by Country (%), 2025 VS 2032
Figure 35. Asia-Pacific Genome Chip Sales Value (2021-2032) & (US$ Million)
Figure 36. Asia-Pacific Genome Chip Sales Value Share by Country (%), 2025 VS 2032
Figure 37. South America Genome Chip Sales Value (2021-2032) & (US$ Million)
Figure 38. South America Genome Chip Sales Value Share by Country (%), 2025 VS 2032
Figure 39. Middle East & Africa Genome Chip Sales Value (2021-2032) & (US$ Million)
Figure 40. Middle East & Africa Genome Chip Sales Value Share by Country (%), 2025 VS 2032
Figure 41. USA Genome Chip Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 42. USA Genome Chip Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 43. USA Genome Chip Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 44. Canada Genome Chip Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 45. Canada Genome Chip Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 46. Canada Genome Chip Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 47. Mexico Genome Chip Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 48. Mexico Genome Chip Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 49. Mexico Genome Chip Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 50. Germany Genome Chip Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 51. Germany Genome Chip Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 52. Germany Genome Chip Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 53. France Genome Chip Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 54. France Genome Chip Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 55. France Genome Chip Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 56. U.K. Genome Chip Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 57. U.K. Genome Chip Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 58. U.K. Genome Chip Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 59. Italy Genome Chip Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 60. Italy Genome Chip Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 61. Italy Genome Chip Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 62. Spain Genome Chip Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 63. Spain Genome Chip Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 64. Spain Genome Chip Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 65. Russia Genome Chip Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 66. Russia Genome Chip Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 67. Russia Genome Chip Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 68. Netherlands Genome Chip Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 69. Netherlands Genome Chip Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 70. Netherlands Genome Chip Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 71. Nordic Countries Genome Chip Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 72. Nordic Countries Genome Chip Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 73. Nordic Countries Genome Chip Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 74. China Genome Chip Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 75. China Genome Chip Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 76. China Genome Chip Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 77. Japan Genome Chip Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 78. Japan Genome Chip Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 79. Japan Genome Chip Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 80. South Korea Genome Chip Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 81. South Korea Genome Chip Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 82. South Korea Genome Chip Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 83. India Genome Chip Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 84. India Genome Chip Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 85. India Genome Chip Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 86. Australia Genome Chip Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 87. Australia Genome Chip Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 88. Australia Genome Chip Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 89. Southeast Asia Genome Chip Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 90. Southeast Asia Genome Chip Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 91. Southeast Asia Genome Chip Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 92. Brazil Genome Chip Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 93. Brazil Genome Chip Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 94. Brazil Genome Chip Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 95. Argentina Genome Chip Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 96. Argentina Genome Chip Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 97. Argentina Genome Chip Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 98. Chile Genome Chip Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 99. Chile Genome Chip Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 100. Chile Genome Chip Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 101. Colombia Genome Chip Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 102. Colombia Genome Chip Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 103. Colombia Genome Chip Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 104. Peru Genome Chip Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 105. Peru Genome Chip Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 106. Peru Genome Chip Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 107. Saudi Arabia Genome Chip Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 108. Saudi Arabia Genome Chip Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 109. Saudi Arabia Genome Chip Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 110. Israel Genome Chip Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 111. Israel Arabia Genome Chip Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 112. Israel Arabia Genome Chip Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 113. UAE Genome Chip Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 114. UAE Genome Chip Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 115. UAE Genome Chip Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 116. Turkey Genome Chip Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 117. Turkey Genome Chip Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 118. Turkey Genome Chip Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 119. Iran Genome Chip Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 120. Iran Genome Chip Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 121. Iran Genome Chip Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 122. Egypt Genome Chip Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 123. Egypt Genome Chip Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 124. Egypt Genome Chip Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 125. Genome Chip Value Chain
Figure 126. Manufacturing Cost Structure
Figure 127. Genome Chip Sales Mode & Process
Figure 128. Direct Comparison with Distribution Share
Figure 129. Distributors Profiles
Figure 130. Years Considered
Figure 131. Research Process
Figure 132. Key Executives Interviewed
Scope & coverage.
Types
- Oligonucleotide DNA Chip
- Complementary DNA Chip
Applications
- Research Centers
- Clinical
- Commercial Molecular Diagnostic
- Others
Companies covered
- Illumnia
- Thermo Fisher
- Agilent
- Scienion AG
- SCHOTT
- Arrayit
- Standard BioTools
- QIAGEN
- GeneCopoeia
- Oxford Gene Technology
- Axela Biosciences
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Genome Chip Sales Value (2021-2032)
- 1.2.2 Global Genome Chip Sales Volume (2021-2032)
- 1.2.3 Global Genome Chip Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Genome Chip Market Dynamics
- 2.1 Genome Chip Industry Trends
- 2.2 Genome Chip Industry Drivers
- 2.3 Genome Chip Industry Opportunities and Challenges
- 2.4 Genome Chip Industry Restraints
3 Genome Chip Market by Company
- 3.1 Global Genome Chip Company Revenue Ranking in 2025
- 3.2 Global Genome Chip Revenue by Company (2021-2026)
- 3.3 Global Genome Chip Sales Volume by Company (2021-2026)
- 3.4 Global Genome Chip Average Price by Company (2021-2026)
- 3.5 Global Genome Chip Company Ranking (2024-2026)
- 3.6 Global Genome Chip Company Manufacturing Base and Headquarters
- 3.7 Global Genome Chip Company Product Type and Application
- 3.8 Global Genome Chip Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Genome Chip Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Genome Chip Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Genome Chip Market by Type
- 4.1 Genome Chip Type Introduction
- 4.1.1 Oligonucleotide DNA Chip
- 4.1.2 Complementary DNA Chip
- 4.2 Global Genome Chip Sales Volume by Type
- 4.2.1 Global Genome Chip Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Genome Chip Sales Volume by Type (2021-2032)
- 4.2.3 Global Genome Chip Sales Volume Share by Type (2021-2032)
- 4.3 Global Genome Chip Sales Value by Type
- 4.3.1 Global Genome Chip Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Genome Chip Sales Value by Type (2021-2032)
- 4.3.3 Global Genome Chip Sales Value Share by Type (2021-2032)
5 Genome Chip Market by Application
- 5.1 Genome Chip Application Introduction
- 5.1.1 Research Centers
- 5.1.2 Clinical
- 5.1.3 Commercial Molecular Diagnostic
- 5.1.4 Others
- 5.2 Global Genome Chip Sales Volume by Application
- 5.2.1 Global Genome Chip Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Genome Chip Sales Volume by Application (2021-2032)
- 5.2.3 Global Genome Chip Sales Volume Share by Application (2021-2032)
- 5.3 Global Genome Chip Sales Value by Application
- 5.3.1 Global Genome Chip Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Genome Chip Sales Value by Application (2021-2032)
- 5.3.3 Global Genome Chip Sales Value Share by Application (2021-2032)
6 Genome Chip Regional Sales and Value Analysis
- 6.1 Global Genome Chip Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Genome Chip Sales by Region (2021-2032)
- 6.2.1 Global Genome Chip Sales by Region: 2021-2026
- 6.2.2 Global Genome Chip Sales by Region (2027-2032)
- 6.3 Global Genome Chip Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Genome Chip Sales Value by Region (2021-2032)
- 6.4.1 Global Genome Chip Sales Value by Region: 2021-2026
- 6.4.2 Global Genome Chip Sales Value by Region (2027-2032)
- 6.5 Global Genome Chip Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Genome Chip Sales Value (2021-2032)
- 6.6.2 North America Genome Chip Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Genome Chip Sales Value (2021-2032)
- 6.7.2 Europe Genome Chip Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Genome Chip Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Genome Chip Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Genome Chip Sales Value (2021-2032)
- 6.9.2 South America Genome Chip Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Genome Chip Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Genome Chip Sales Value Share by Country, 2025 VS 2032
7 Genome Chip Country-level Sales and Value Analysis
- 7.1 Global Genome Chip Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Genome Chip Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Genome Chip Sales by Country (2021-2032)
- 7.3.1 Global Genome Chip Sales by Country (2021-2026)
- 7.3.2 Global Genome Chip Sales by Country (2027-2032)
- 7.4 Global Genome Chip Sales Value by Country (2021-2032)
- 7.4.1 Global Genome Chip Sales Value by Country (2021-2026)
- 7.4.2 Global Genome Chip Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Genome Chip Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Genome Chip Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Genome Chip Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Genome Chip Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Genome Chip Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Genome Chip Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Genome Chip Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Genome Chip Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Genome Chip Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Genome Chip Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Genome Chip Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Genome Chip Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Genome Chip Sales Value Growth Rate (2021-2032)
- 7.9.2 France Genome Chip Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Genome Chip Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Genome Chip Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Genome Chip Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Genome Chip Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Genome Chip Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Genome Chip Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Genome Chip Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Genome Chip Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Genome Chip Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Genome Chip Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Genome Chip Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Genome Chip Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Genome Chip Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Genome Chip Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Genome Chip Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Genome Chip Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Genome Chip Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Genome Chip Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Genome Chip Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Genome Chip Sales Value Growth Rate (2021-2032)
- 7.16.2 China Genome Chip Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Genome Chip Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Genome Chip Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Genome Chip Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Genome Chip Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Genome Chip Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Genome Chip Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Genome Chip Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Genome Chip Sales Value Growth Rate (2021-2032)
- 7.19.2 India Genome Chip Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Genome Chip Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Genome Chip Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Genome Chip Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Genome Chip Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Genome Chip Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Genome Chip Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Genome Chip Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Genome Chip Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Genome Chip Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Genome Chip Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Genome Chip Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Genome Chip Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Genome Chip Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Genome Chip Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Genome Chip Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Genome Chip Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Genome Chip Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Genome Chip Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Genome Chip Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Genome Chip Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Genome Chip Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Genome Chip Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Genome Chip Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Genome Chip Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Genome Chip Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Genome Chip Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Genome Chip Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Genome Chip Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Genome Chip Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Genome Chip Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Genome Chip Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Genome Chip Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Genome Chip Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Genome Chip Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Genome Chip Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Genome Chip Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Genome Chip Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Genome Chip Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Genome Chip Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Genome Chip Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Illumnia
- 8.1.1 Illumnia Company Information
- 8.1.2 Illumnia Business Overview
- 8.1.3 Illumnia Genome Chip Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Illumnia Genome Chip Product Portfolio
- 8.1.5 Illumnia Recent Developments
- 8.2 Thermo Fisher
- 8.2.1 Thermo Fisher Company Information
- 8.2.2 Thermo Fisher Business Overview
- 8.2.3 Thermo Fisher Genome Chip Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Thermo Fisher Genome Chip Product Portfolio
- 8.2.5 Thermo Fisher Recent Developments
- 8.3 Agilent
- 8.3.1 Agilent Company Information
- 8.3.2 Agilent Business Overview
- 8.3.3 Agilent Genome Chip Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Agilent Genome Chip Product Portfolio
- 8.3.5 Agilent Recent Developments
- 8.4 Scienion AG
- 8.4.1 Scienion AG Company Information
- 8.4.2 Scienion AG Business Overview
- 8.4.3 Scienion AG Genome Chip Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Scienion AG Genome Chip Product Portfolio
- 8.4.5 Scienion AG Recent Developments
- 8.5 SCHOTT
- 8.5.1 SCHOTT Company Information
- 8.5.2 SCHOTT Business Overview
- 8.5.3 SCHOTT Genome Chip Sales, Value and Gross Margin (2021-2026)
- 8.5.4 SCHOTT Genome Chip Product Portfolio
- 8.5.5 SCHOTT Recent Developments
- 8.6 Arrayit
- 8.6.1 Arrayit Company Information
- 8.6.2 Arrayit Business Overview
- 8.6.3 Arrayit Genome Chip Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Arrayit Genome Chip Product Portfolio
- 8.6.5 Arrayit Recent Developments
- 8.7 Standard BioTools
- 8.7.1 Standard BioTools Company Information
- 8.7.2 Standard BioTools Business Overview
- 8.7.3 Standard BioTools Genome Chip Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Standard BioTools Genome Chip Product Portfolio
- 8.7.5 Standard BioTools Recent Developments
- 8.8 QIAGEN
- 8.8.1 QIAGEN Company Information
- 8.8.2 QIAGEN Business Overview
- 8.8.3 QIAGEN Genome Chip Sales, Value and Gross Margin (2021-2026)
- 8.8.4 QIAGEN Genome Chip Product Portfolio
- 8.8.5 QIAGEN Recent Developments
- 8.9 GeneCopoeia
- 8.9.1 GeneCopoeia Company Information
- 8.9.2 GeneCopoeia Business Overview
- 8.9.3 GeneCopoeia Genome Chip Sales, Value and Gross Margin (2021-2026)
- 8.9.4 GeneCopoeia Genome Chip Product Portfolio
- 8.9.5 GeneCopoeia Recent Developments
- 8.10 Oxford Gene Technology
- 8.10.1 Oxford Gene Technology Company Information
- 8.10.2 Oxford Gene Technology Business Overview
- 8.10.3 Oxford Gene Technology Genome Chip Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Oxford Gene Technology Genome Chip Product Portfolio
- 8.10.5 Oxford Gene Technology Recent Developments
- 8.11 Axela Biosciences
- 8.11.1 Axela Biosciences Company Information
- 8.11.2 Axela Biosciences Business Overview
- 8.11.3 Axela Biosciences Genome Chip Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Axela Biosciences Genome Chip Product Portfolio
- 8.11.5 Axela Biosciences Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Genome Chip Value Chain Analysis
- 9.1.1 Genome Chip Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Genome Chip Sales Mode & Process
- 9.2 Genome Chip Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Genome Chip Distributors
- 9.2.3 Genome Chip Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst